Literature DB >> 18243729

Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process.

Christophe Michel Raynaud1, Laure Sabatier, Ophelie Philipot, Ken André Olaussen, Jean-Charles Soria.   

Abstract

Telomeres form specialized structures at the ends of eukaryotic chromosomes, preventing them from being wrongly recognized as DNA damage. The human telomere DNA sequence is a tandem repetition of the sequence TTAGGG. In normal cells, the DNA replication machinery is unable to completely duplicate the telomeric DNA; thus, telomeres are shortened after every cell division. Having reached a critical length, telomeres may be recognized as double strand break DNA lesions, and cells eventually enter senescence. Carcinogenesis is a multistep process involving multiple mutations and chromosomal aberrations. One of the most prevalent aberrations in pre-cancerous lesions is telomere shortening and telomerase activation. We discuss the role and homeostasis of telomeres in normal cells and their implication in the early steps of carcinogenesis. We also discuss various techniques used, and their limitations, in the study of telomeres and genome instability and their role in carcinogenesis and related genomic modifications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18243729     DOI: 10.1016/j.critrevonc.2007.11.006

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  26 in total

1.  Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients.

Authors:  Junfeng Xu; Wen-Shin Chang; Chia-Wen Tsai; Da-Tian Bau; Yifan Xu; John W Davis; Timothy C Thompson; Christopher J Logothetis; Jian Gu
Journal:  EBioMedicine       Date:  2020-01-22       Impact factor: 8.143

2.  Enzymes used in molecular biology: a useful guide.

Authors:  Laure Rittié; Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2008-09-03       Impact factor: 5.782

3.  The relationship between telomere length and clinicopathologic characteristics in colorectal cancers among Tunisian patients.

Authors:  Raja Mzahma; Maher Kharrat; Fadhel Fetiriche; Mounir Ben Moussa; Zoubeir Ben Safta; Chadli Dziri; AbdelJelil Zaouche; Habiba Chaabouni-Bouhamed
Journal:  Tumour Biol       Date:  2015-06-06

4.  Role of senescence and mitotic catastrophe in cancer therapy.

Authors:  Richa Singh; Jasmine George; Yogeshwer Shukla
Journal:  Cell Div       Date:  2010-01-21       Impact factor: 5.130

5.  What mechanisms/processes underlie radiation-induced genomic instability?

Authors:  Andrei V Karotki; Keith Baverstock
Journal:  Cell Mol Life Sci       Date:  2012-09-06       Impact factor: 9.261

6.  RNAi targeting of hTERT gene expression induces apoptosis and inhibits the proliferation of lung cancer cells.

Authors:  Linhu Ge; Wenlong Shao; Yangde Zhang; Yuan Qiu; Dong Cui; Donghai Huang; Zhansheng Deng
Journal:  Oncol Lett       Date:  2011-08-19       Impact factor: 2.967

Review 7.  Potential mechanisms of disease progression and management of advanced-phase chronic myeloid leukemia.

Authors:  Elias J Jabbour; Timothy P Hughes; Jorge E Cortés; Hagop M Kantarjian; Andreas Hochhaus
Journal:  Leuk Lymphoma       Date:  2013-11-12

Review 8.  Crosstalk between telomere maintenance and radiation effects: A key player in the process of radiation-induced carcinogenesis.

Authors:  Grace Shim; Michelle Ricoul; William M Hempel; Edouard I Azzam; Laure Sabatier
Journal:  Mutat Res Rev Mutat Res       Date:  2014-01-31       Impact factor: 5.657

9.  Gene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.

Authors:  Masahiro Kato; Masahiro Nakayama; Minako Agata; Kenichi Yoshida
Journal:  Tumour Biol       Date:  2012-12-18

10.  A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma.

Authors:  Qing Lan; Richard Cawthon; Min Shen; Stephanie J Weinstein; Jarmo Virtamo; Unhee Lim; H Dean Hosgood; Demetrius Albanes; Nathaniel Rothman
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.